Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3927)
All Articles published online
|
Aug 15, 2001 (publication date) through May 2, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Tibble J, Bjarnason I. Non-invasive investigation of inflammatory bowel disease. World J Gastroenterol 2001; 7(4): 460-465 [PMID: 11819811 DOI: 10.3748/wjg.v7.i4.460] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v7/i4/460.htm |
| Number | Citing Articles |
| 1 |
C. Piras, A. Soggiu, V. Greco, A. Cassinotti, G. Maconi, S. Ardizzone, A. Amoresano, G. Bianchi Porro, L. Bonizzi, P. Roncada. Serum protein profiling of early and advanced stage Crohn's disease. EuPA Open Proteomics 2014; 3: 48 doi: 10.1016/j.euprot.2014.02.010
|
| 2 |
James Turvill, Lisa Rook, Maxine Rawle, Gerry Robins, Simon Smale, Prashant Kant, Anne Phillips. Validation of a care pathway for the use of faecal calprotectin in monitoring patients with Crohn's disease. Frontline Gastroenterology 2017; 8(3): 183 doi: 10.1136/flgastro-2016-100780
|
| 3 |
I. Bjarnason, L. Maiden, K. Takeuchi. Gastroenterology Yesterday — Today — Tomorrow: A Review and Preview. Falk Symposium 2005; 144: 253 doi: 10.1007/1-4020-2916-0_24
|
| 4 |
Atakan Yeşil, Ebubekir Şenateş, İbrahim Vedat Bayoğlu, Emrullah Düzgün Erdem, Refi k Demirtunç, Ayşe Oya Kurdaş Övünç. Red Cell Distribution Width: A Novel Marker of Activity in Infl ammatory Bowel Disease. Gut and Liver 2011; 5(4): 460 doi: 10.5009/gnl.2011.5.4.460
|
| 5 |
Gerard E. Mullin. Textbook of Natural Medicine. 2020; : 1473 doi: 10.1016/B978-0-323-43044-9.00186-2
|
| 6 |
J.P. Gisbert, A.G. McNicholl. Questions and answers on the role of faecal calprotectin as a biological marker in inflammatory bowel disease. Digestive and Liver Disease 2009; 41(1): 56 doi: 10.1016/j.dld.2008.05.008
|
| 7 |
Ricardo A Caicedo, Martha Douglas-Escobar, Nan Li, Josef Neu. Gastroenterology and Nutrition: Neonatology Questions and Controversies. 2008; : 93 doi: 10.1016/B978-1-4160-3160-4.10006-9
|
| 8 |
Annette Prohl, Wieland Schroedl, Heidrun Rhode, Petra Reinhold. Acute phase proteins as local biomarkers of respiratory infection in calves. BMC Veterinary Research 2015; 11(1) doi: 10.1186/s12917-015-0485-7
|
| 9 |
Eun Soo Kim. Optimal Usage of Fecal Calprotectin for Intestinal Diseases. The Korean Journal of Medicine 2018; 93(4): 364 doi: 10.3904/kjm.2018.93.4.364
|
| 10 |
Ioannis D. Kostakis, Kyriaki G. Cholidou, Konstantinos Kallianidis, Despina Perrea, Aristidis Antsaklis. The role of calprotectin in obstetrics and gynecology. European Journal of Obstetrics & Gynecology and Reproductive Biology 2010; 151(1): 3 doi: 10.1016/j.ejogrb.2010.03.006
|
| 11 |
Abdullah Glil Alkushi, Sara T. Elazab, Ahmed Abdelfattah-Hassan, Hala Mahfouz, Gamal A. Salem, Nagwa I. Sheraiba, Eman A. A. Mohamed, Mai S. Attia, Eman S. El-Shetry, Ayman A. Saleh, Naser A. ElSawy, Doaa Ibrahim. Multi-Strain-Probiotic-Loaded Nanoparticles Reduced Colon Inflammation and Orchestrated the Expressions of Tight Junction, NLRP3 Inflammasome and Caspase-1 Genes in DSS-Induced Colitis Model. Pharmaceutics 2022; 14(6): 1183 doi: 10.3390/pharmaceutics14061183
|
| 12 |
Jost Langhorst, Sigrid Elsenbruch, Julia Koelzer, Andreas Rueffer, Andreas Michalsen, Gustav J Dobos. Noninvasive Markers in the Assessment of Intestinal Inflammation in Inflammatory Bowel Diseases: Performance of Fecal Lactoferrin, Calprotectin, and PMN-Elastase, CRP, and Clinical Indices. The American Journal of Gastroenterology 2008; 103(1): 162 doi: 10.1111/j.1572-0241.2007.01556.x
|
| 13 |
Camilia R. Martin, Ricardo A. Caicedo, W. Allan Walker. Gastroenterology and Nutrition: Neonatology Questions and Controversies. 2012; : 39 doi: 10.1016/B978-1-4377-2603-9.00004-1
|
| 14 |
Carmelo Scarpignato, Richard H. Hunt. Nonsteroidal Antiinflammatory Drug-Related Injury to the Gastrointestinal Tract: Clinical Picture, Pathogenesis, and Prevention. Gastroenterology Clinics of North America 2010; 39(3): 433 doi: 10.1016/j.gtc.2010.08.010
|
| 15 |
Kaija-Leena Kolho, Taneli Raivio, Harry Lindahl, Erkki Savilahti. Fecal calprotectin remains high during glucocorticoid therapy in children with inflammatory bowel disease. Scandinavian Journal of Gastroenterology 2006; 41(6): 720 doi: 10.1080/00365520500419623
|
| 16 |
Tara J. Cepon‐Robins, Elizabeth K. Mallott, Isabella C. Recca, Theresa E. Gildner. Exploring biocultural determinants of intestinal health: Do resource access and parasite exposure contribute to intestinal inflammation among a preliminary sample of children in rural Mississippi?. American Journal of Biological Anthropology 2023; 182(4): 606 doi: 10.1002/ajpa.24574
|
| 17 |
T. Bjørkkjær, L. A. Brunborg, G. Arslan, R. A. Lind, J. G. Brun, M. Valen, B. Klementsen, A. Berstad, L. Frøyland. Reduced joint pain after short-term duodenal administration of seal oil in patients with inflammatory bowel disease: comparison with soy oil. Scandinavian Journal of Gastroenterology 2004; 39(11): 1088 doi: 10.1080/00365520410009429
|
| 18 |
Britta Noebauer, Lejla Ramic, Andrea Konstantin, Christina Zachbauer, Elisa Einwallner. Analytical evaluation of a fully automated immunoassay for faecal calprotectin in a paediatric setting. Biochemia Medica 2017; 27(3) doi: 10.11613/BM.2017.030710
|
| 19 |
Susanta Lahiri, Moumita Maiti, Kaustab Ghosh. Production and separation of 111In: an important radionuclide in life sciences: a mini review. Journal of Radioanalytical and Nuclear Chemistry 2013; 297(3): 309 doi: 10.1007/s10967-012-2344-3
|
| 20 |
N Laforgia, ME Baldassarre, G Pontrelli, F Indrio, MA Altomare, G Di Bitonto, A Mautone. Calprotectin levels in meconium. Acta Paediatrica 2003; 92(4): 463 doi: 10.1111/j.1651-2227.2003.tb00579.x
|
| 21 |
Roberta Caccaro, Renata D’Incá, Giacomo Carlo Sturniolo. Clinical utility of calprotectin and lactoferrin as markers of inflammation in patients with inflammatory bowel disease. Expert Review of Clinical Immunology 2010; 6(4): 551 doi: 10.1586/eci.10.26
|
| 22 |
M. Schaufelberger, I. Ekman, E. Björnsson, E. Kalaitzakis, T. Ekman. Intestinal paracellular permeability is not affected in chronic congestive heart failure. European Journal of Heart Failure 2007; 9(6-7): 574 doi: 10.1016/j.ejheart.2007.02.005
|
| 23 |
Iftikhar Ahmed, Faisal Fayyaz, Moneeb Nasir, Zafar Niaz, Manuele Furnari, Lorna Perry. Extending landscape of volatile metabolites as novel diagnostic biomarkers of inflammatory bowel disease – a review. Scandinavian Journal of Gastroenterology 2016; 51(4): 385 doi: 10.3109/00365521.2015.1105286
|
| 24 |
|
| 25 |
Shapur Ikhtaire, Mohammad Sharif Shajib, Walter Reinisch, Waliul Islam Khan. Fecal calprotectin: its scope and utility in the management of inflammatory bowel disease. Journal of Gastroenterology 2016; 51(5): 434 doi: 10.1007/s00535-016-1182-4
|
| 26 |
Heriberto Rodriguez, Jan S. Suchodolski, Nora Berghoff, Jörg M. Steiner. Development and analytic validation of a gas chromatography–mass spectrometry method for the measurement of sugar probes in canine serum. American Journal of Veterinary Research 2009; 70(3): 320 doi: 10.2460/ajvr.70.3.320
|
| 27 |
Tawfik El-Raouf. Long Pentraxin PTX 3 and Faecal Calprotectin as a Non Invasive Biomarkers for Ulcerative Colitis. Archives of Clinical Gastroenterology 2017; : 011 doi: 10.17352/2455-2283.000030
|
| 28 |
I. Bjarnason, K. Takeuchi, A. Bjarnason, S. N. Adler, K. Teahon. The G.U.T. of gut. Scandinavian Journal of Gastroenterology 2004; 39(9): 807 doi: 10.1080/00365520410003326
|
| 29 |
Christine Prell, Dorothea Nagel, Folke Freudenberg, Andrea Schwarzer, Sibylle Koletzko. Comparison of three tests for faecal calprotectin in children and young adults: a retrospective monocentric study. BMJ Open 2014; 4(5): e004558 doi: 10.1136/bmjopen-2013-004558
|
| 30 |
Monika Pruenster, Angela R. M. Kurz, Kyoung-Jin Chung, Xiao Cao-Ehlker, Stephanie Bieber, Claudia F. Nussbaum, Susanne Bierschenk, Tanja K. Eggersmann, Ina Rohwedder, Kristina Heinig, Roland Immler, Markus Moser, Uwe Koedel, Sandra Gran, Rodger P. McEver, Dietmar Vestweber, Admar Verschoor, Tomas Leanderson, Triantafyllos Chavakis, Johannes Roth, Thomas Vogl, Markus Sperandio. Extracellular MRP8/14 is a regulator of β2 integrin-dependent neutrophil slow rolling and adhesion. Nature Communications 2015; 6(1) doi: 10.1038/ncomms7915
|
| 31 |
Maria Gloria Mumolo, Lorenzo Bertani, Linda Ceccarelli, Gabriella Laino, Giorgia Di Fluri, Eleonora Albano, Gherardo Tapete, Francesco Costa. From bench to bedside: Fecal calprotectin in inflammatory bowel diseases clinical setting. World Journal of Gastroenterology 2018; 24(33): 3681-3694 doi: 10.3748/wjg.v24.i33.3681
|
| 32 |
Peter Laszlo Lakatos, Lajos Sandor Kiss, Karoly Palatka, Istvan Altorjay, Peter Antal-Szalmas, Eszter Palyu, Miklos Udvardy, Tamas Molnar, Klaudia Farkas, Gabor Veres, Jolan Harsfalvi, Janos Papp, Maria Papp. Serum lipopolysaccharide-binding protein and soluble CD14 are markers of disease activity in patients with Crohnʼs disease. Inflammatory Bowel Diseases 2011; 17(3): 767 doi: 10.1002/ibd.21402
|
| 33 |
Jan M Ehrchen, Cord Sunderkötter, Dirk Foell, Thomas Vogl, Johannes Roth. The endogenous Toll–like receptor 4 agonist S100A8/S100A9 (calprotectin) as innate amplifier of infection, autoimmunity, and cancer. Journal of Leukocyte Biology 2009; 86(3): 557 doi: 10.1189/jlb.1008647
|
| 34 |
G. M. Damen, E. E. S. Nieuwenhuis. Niet-invasieve markers bij inflammatoire darmziekten op de kinderleeftijd. Tijdschrift voor kindergeneeskunde 2005; 73(1): 251 doi: 10.1007/BF03061588
|
| 35 |
Adil Omer Karakus, Ethem Mutlu Temizel, Duygu Udum. Determination of the relationships between serum amyloid A, serum calprotectin and fecal calprotectin in healthy and infectious diarrheic calves and their diagnostic significances as inflammatory markers. Research in Veterinary Science 2023; 164: 105041 doi: 10.1016/j.rvsc.2023.105041
|
| 36 |
D. R. van Langenberg, R. B. Gearry, H‐L. Wong, M. Ward, P. R. Gibson. The potential value of faecal lactoferrin as a screening test in hospitalized patients with diarrhoea. Internal Medicine Journal 2010; 40(12): 819 doi: 10.1111/j.1445-5994.2009.02102.x
|
| 37 |
Albert E. Jergens. Clinical Assessment of Disease Activity for Canine Inflammatory Bowel Disease. Journal of the American Animal Hospital Association 2004; 40(6): 437 doi: 10.5326/0400437
|
| 38 |
Serkan Torun, Bilge Demirel Tunc, Burak Suvak, Hakan Yildiz, Adnan Tas, Abdurrahim Sayilir, Yasemin Ozin Ozderin, Yavuz Beyazit, Ertugrul Kayacetin. Assessment of neutrophil-lymphocyte ratio in ulcerative colitis: A promising marker in predicting disease severity. Clinics and Research in Hepatology and Gastroenterology 2012; 36(5): 491 doi: 10.1016/j.clinre.2012.06.004
|
| 39 |
Tarang Taghvaei, Iradj Maleki, Farshad Nagshvar, Hafez Fakheri, Vahid Hosseini, Seyed Mohammad Valizadeh, Hassan Neishaboori. Fecal calprotectin and ulcerative colitis endoscopic activity index as indicators of mucosal healing in ulcerative colitis. Internal and Emergency Medicine 2015; 10(3): 321 doi: 10.1007/s11739-014-1144-x
|
| 40 |
Malgorzata Krzystek-Korpacka, Katarzyna Neubauer, Malgorzata Matusiewicz. Circulating midkine in Crohnʼs disease: Clinical implications. Inflammatory Bowel Diseases 2010; 16(2): 208 doi: 10.1002/ibd.21011
|
| 41 |
Emily L. O'Reilly, Anita Horvatić, Josipa Kuleš, Andrea Gelemanović, Vladimir Mrljak, Yixin Huang, Nicola Brady, Christopher C. Chadwick, P. David Eckersall, Alison Ridyard. Faecal proteomics in the identification of biomarkers to differentiate canine chronic enteropathies. Journal of Proteomics 2022; 254: 104452 doi: 10.1016/j.jprot.2021.104452
|
| 42 |
Jacopo Gervasoni, Arcangelo Schiattarella, Valentina Giorgio, Aniello Primiano, Consuelo Russo, Valentina Tesori, Franco Scaldaferri, Andrea Urbani, Cecilia Zuppi, Silvia Persichilli. Validation of an LC-MS/MS Method for Urinary Lactulose and Mannitol Quantification: Results in Patients with Irritable Bowel Syndrome. Disease Markers 2016; 2016: 1 doi: 10.1155/2016/5340386
|
| 43 |
Shabana F. Pasha, Jonathan A. Leighton. Inflammatory Bowel Disease. 2011; : 231 doi: 10.1007/978-1-60327-433-3_15
|
| 44 |
L. Amati, M.E. Passeri, F. Selicato, M.L. Mastronardi, A. Penna, E. Jirillo, V. Covelli. New Insights into the Biological and Clinical Significance of Fecal Calprotectin in Inflammatory Bowel Disease. Immunopharmacology and Immunotoxicology 2006; 28(4): 665 doi: 10.1080/08923970601067326
|
| 45 |
Katarzyna Klimczak, Liliana Lykowska-Szuber, Piotr Eder, Iwona Krela-Kazmierczak, Kamila Stawczyk-Eder, Aleksandra Szymczak, Michal Michalak, Adam Studniarek, Krzysztof Linke. The diagnostic usefulness of fecal lactoferrin in the assessment of Crohn's disease activity. European Journal of Internal Medicine 2015; 26(8): 623 doi: 10.1016/j.ejim.2015.06.015
|
| 46 |
MATTHIAS BRUEWER, STANISLAV SAMARIN, ASMA NUSRAT. Inflammatory Bowel Disease and the Apical Junctional Complex. Annals of the New York Academy of Sciences 2006; 1072(1): 242 doi: 10.1196/annals.1326.017
|
| 47 |
Scott E Evans, Michael J Tuvim, Jiexin Zhang, Derek T Larson, Cesar D García, Sylvia Martinez Pro, Kevin R Coombes, Burton F Dickey. Host lung gene expression patterns predict infectious etiology in a mouse model of pneumonia. Respiratory Research 2010; 11(1) doi: 10.1186/1465-9921-11-101
|
| 48 |
Hans J. Vogel. Lactoferrin, a bird’s eye view. Biochemistry and Cell Biology 2012; 90(3): 233 doi: 10.1139/o2012-016
|
| 49 |
Malgorzata Krzystek-Korpacka, Katarzyna Neubauer, Malgorzata Matusiewicz. Clinical relevance of circulating midkine in ulcerative colitis. Clinical Chemistry and Laboratory Medicine 2009; 47(9) doi: 10.1515/CCLM.2009.248
|
| 50 |
Roberta Caccaro, Imerio Angriman, Renata D’Incà. Relevance of fecal calprotectin and lactoferrin in the post-operative management of inflammatory bowel diseases. World Journal of Gastrointestinal Surgery 2016; 8(3): 193-201 doi: 10.4240/wjgs.v8.i3.193
|
| 51 |
Renata D’Incà, Giulia Sturniolo. Biomarkers in IBD: What to Utilize for the Diagnosis?. Diagnostics 2023; 13(18): 2931 doi: 10.3390/diagnostics13182931
|
| 52 |
Francesca Palone, Roberta Vitali, Salvatore Cucchiara, Maria Pierdomenico, Anna Negroni, Marina Aloi, Federica Nuti, Carla Felice, Alessandro Armuzzi, Laura Stronati. Role of HMGB1 as a Suitable Biomarker of Subclinical Intestinal Inflammation and Mucosal Healing in Patients with Inflammatory Bowel Disease. Inflammatory Bowel Diseases 2014; 20(8): 1448 doi: 10.1097/MIB.0000000000000113
|
| 53 |
|
| 54 |
Ralph S. Lachman. Taybi and Lachman's Radiology of Syndromes, Metabolic Disorders and Skeletal Dysplasias. 2007; : 404 doi: 10.1016/B978-0-323-01931-6.50017-7
|
| 55 |
Anna Vaiopoulou, Maria Gazouli, George Theodoropoulos, George Zografos. Current Advantages in the Application of Proteomics in Inflammatory Bowel Disease. Digestive Diseases and Sciences 2012; 57(11): 2755 doi: 10.1007/s10620-012-2291-4
|
| 56 |
James Turvill. Mapping of Crohn's disease outcomes to faecal calprotectin levels in patients maintained on biologic therapy. Frontline Gastroenterology 2014; 5(3): 167 doi: 10.1136/flgastro-2014-100441
|
| 57 |
Jacopo Gervasoni, Aniello Primiano, Cristina Graziani, Franco Scaldaferri, Antonio Gasbarrini, Andrea Urbani, Silvia Persichilli. Validation of UPLC-MS/MS Method for Determination of Urinary Lactulose/Mannitol. Molecules 2018; 23(10): 2705 doi: 10.3390/molecules23102705
|
| 58 |
Mirja Mindemark, Anders Larsson. Ruling out IBD: Estimation of the possible economic effects of pre-endoscopic screening with F-calprotectin. Clinical Biochemistry 2012; 45(7-8): 552 doi: 10.1016/j.clinbiochem.2011.10.015
|
| 59 |
Sajjad Moradi, Reza Bagheri, Parsa Amirian, Mahsa Zarpoosh, Neda Cheraghloo, Alexei Wong, Mehdi Zobeiri, Mohammad Hassan Entezari. Effects of Spirulina supplementation in patients with ulcerative colitis: a double-blind, placebo-controlled randomized trial. BMC Complementary Medicine and Therapies 2024; 24(1) doi: 10.1186/s12906-024-04400-w
|
| 60 |
Óscar Pastor Rojo, Antonio López San Román, Eduardo Albéniz Arbizu, Antonio de la Hera Martínez, Eduardo Ripoll Sevillano, Agustín Albillos Martínez. Serum lipopolysaccharide-binding protein in endotoxemic patients with inflammatory bowel disease. Inflammatory Bowel Diseases 2007; 13(3): 269 doi: 10.1002/ibd.20019
|
| 61 |
Melanie D. Craven, Robert J. Washabau. Comparative pathophysiology and management of protein‐losing enteropathy. Journal of Veterinary Internal Medicine 2019; 33(2): 383 doi: 10.1111/jvim.15406
|
| 62 |
D. DESAI, W. A. FAUBION, W. J. SANDBORN. Review article: biological activity markers in inflammatory bowel disease. Alimentary Pharmacology & Therapeutics 2007; 25(3): 247 doi: 10.1111/j.1365-2036.2006.03184.x
|
| 63 |
Tomoko Kanki, Takashige Kuwabara, Jun Morinaga, Hirotaka Fukami, Shuro Umemoto, Daisuke Fujimoto, Teruhiko Mizumoto, Manabu Hayata, Yutaka Kakizoe, Yuichiro Izumi, Saeko Tajiri, Tetsuya Tajiri, Kenichiro Kitamura, Masashi Mukoyama. The predictive role of serum calprotectin on mortality in hemodialysis patients with high phosphoremia. BMC Nephrology 2020; 21(1) doi: 10.1186/s12882-020-01812-x
|
| 64 |
Şeyma Şumnu, Özgür Mehtap, Sinan Mersin, Tayfur Toptaş, Gözde Görür, Ayfer Gedük, Serkan Ünal, Merve Gökçen Polat, Kemal Aygün, Emel Merve Yenihayat, Hayrunnisa Albayrak, Meral Uluköylü Mengüç, Pınar Tarkun, Abdullah Hacıhanifioğlu. Serum calprotectin (S100A8/A9) levels as a new potential biomarker of treatment response in Hodgkin lymphoma. International Journal of Laboratory Hematology 2021; 43(4): 638 doi: 10.1111/ijlh.13559
|
| 65 |
Anastasios Koulaouzidis, Sarah Douglas, Marie A. Rogers, Ian D. Arnott, John N. Plevris. Fecal calprotectin: A selection tool for small bowel capsule endoscopy in suspected IBD with prior negative bi-directional endoscopy. Scandinavian Journal of Gastroenterology 2011; 46(5): 561 doi: 10.3109/00365521.2011.551835
|
| 66 |
Javier P. Gisbert, Adrian G. McNicholl, Fernando Gomollon. Questions and answers on the role of fecal lactoferrin as a biological marker in inflammatory bowel disease. Inflammatory Bowel Diseases 2009; 15(11): 1746 doi: 10.1002/ibd.20920
|
| 67 |
Yuan Zhao, Wanting Qi, Can Huang, Yangzhong Zhou, Qian Wang, Xinping Tian, Mengtao Li, Yan Zhao, Xiaofeng Zeng, Jiuliang Zhao. Serum Calprotectin as a Potential Predictor of Microvascular Manifestations in Patients with Antiphospholipid Syndrome. Rheumatology and Therapy 2023; 10(6): 1769 doi: 10.1007/s40744-023-00610-9
|
| 68 |
Takuya Kotani, Masaki Ikemoto, Shogo Matsuda, Ryota Masutani, Tohru Takeuchi. Human MIKO-1, a Hybrid Protein That Regulates Macrophage Function, Suppresses Lung Fibrosis in a Mouse Model of Bleomycin-Induced Interstitial Lung Disease. International Journal of Molecular Sciences 2022; 23(17): 9669 doi: 10.3390/ijms23179669
|
| 69 |
Antje Ballauff, Tobias G. Wenzl, Ralf Bialek, Heiko Witt, Hassan Y. Naim. Pädiatrische Gastroenterologie, Hepatologie und Ernährung. 2013; : 107 doi: 10.1007/978-3-642-24710-1_3
|
| 70 |
Tara J. Cepon‐Robins, Theresa E. Gildner, Joshua Schrock, Geeta Eick, Ali Bedbury, Melissa A. Liebert, Samuel S. Urlacher, Felicia C. Madimenos, Christopher J. Harrington, Dorsa Amir, Richard G. Bribiescas, Lawrence S. Sugiyama, James J. Snodgrass. Soil‐transmitted helminth infection and intestinal inflammation among the Shuar of Amazonian Ecuador. American Journal of Physical Anthropology 2019; 170(1): 65 doi: 10.1002/ajpa.23897
|
| 71 |
Zhi-Zheng Ge, Yun-Biao Hu, Shu-Dong Xiao. Capsule endoscopy in diagnosis of small bowel Crohn’s disease. World Journal of Gastroenterology 2004; 10(9): 1349-1352 doi: 10.3748/wjg.v10.i9.1349
|
| 72 |
Basak Cakal, Ayla Gokmen Akoz, Yucel Ustundag, Mesut Yalinkilic, Aysel Ulker, Handan Ankarali. Red Cell Distribution Width for Assessment of Activity of Inflammatory Bowel Disease. Digestive Diseases and Sciences 2009; 54(4): 842 doi: 10.1007/s10620-008-0436-2
|
| 73 |
Monika Pruenster, Thomas Vogl, Johannes Roth, Markus Sperandio. S100A8/A9: From basic science to clinical application. Pharmacology & Therapeutics 2016; 167: 120 doi: 10.1016/j.pharmthera.2016.07.015
|
| 74 |
N. V. Filipenko. NONINVASIVE DIAGNOSIS OF COLORECTAL CANCER AND ULCERATIVE COLITIS BASED ON THE COMBINED USE OF FECAL LACTOFERRIN AND IMMUNOCHEMICAL HEMOCCULT TEST. Health and Ecology Issues 2011; (1): 142 doi: 10.51523/2708-6011.2011-8-1-28
|
| 75 |
Fernando Magro, Susana Lopes, Marco Silva, Rosa Coelho, Francisco Portela, Diogo Branquinho, Luís Correia, Samuel Fernandes, Marília Cravo, Paulo Caldeira, Helena Tavares de Sousa, Marta Patita, Paula Lago, Jaime Ramos, Joana Afonso, Isabel Redondo, Patrícia Machado, George Philip, Joanne Lopes, Fátima Carneiro. Soluble human Suppression of Tumorigenicity 2 is associated with endoscopic activity in patients with moderate-to-severe ulcerative colitis treated with golimumab. Therapeutic Advances in Gastroenterology 2019; 12: 175628481986914 doi: 10.1177/1756284819869141
|
| 76 |
Kohki Okada, Hiroshi Itoh, Yasuhiko Kamikubo, Souichi Adachi, Masaki Ikemoto. Establishment of S100A8 Transgenic Rats to Understand Innate Property of S100A8 and Its Immunological Role. Inflammation 2018; 41(1): 59 doi: 10.1007/s10753-017-0664-8
|
| 77 |
Scott E. Plevy, Miguel Reguiero. Measuring Immunity. 2005; : 525 doi: 10.1016/B978-012455900-4/50308-1
|
| 78 |
Alexander Hanania, Zhi-Dong Jiang, Casey Smiley, Todd Lasco, Kevin W. Garey, Herbert L. DuPont. Fecal Calprotectin in the Diagnosis of Clostridium difficile Infection. Infectious Diseases in Clinical Practice 2016; 24(1): 31 doi: 10.1097/IPC.0000000000000312
|
| 79 |
Dorota Walkiewicz, Steven L. Werlin, Daryl Fish, Mathew Scanlon, Patrick Hanaway, Subra Kugathasan. Fecal calprotectin is useful in predicting disease relapse in pediatric inflammatory bowel disease. Inflammatory Bowel Diseases 2008; 14(5): 669 doi: 10.1002/ibd.20376
|
| 80 |
Michel A. Boivin, Dongmei Ye, John C. Kennedy, Rana Al-Sadi, Chris Shepela, Thomas Y. Ma. Mechanism of glucocorticoid regulation of the intestinal tight junction barrier. American Journal of Physiology-Gastrointestinal and Liver Physiology 2007; 292(2): G590 doi: 10.1152/ajpgi.00252.2006
|
| 81 |
Andrew D. Sutherland, Richard B. Gearry, Frank A. Frizelle. Review of Fecal Biomarkers in Inflammatory Bowel Disease. Diseases of the Colon & Rectum 2008; 51(8): 1283 doi: 10.1007/s10350-008-9310-8
|
| 82 |
Irene Di Ceglie, Arjen B. Blom, Robab Davar, Colin Logie, Joost H. A. Martens, Ehsan Habibi, Lisa‐Marie Böttcher, Johannes Roth, Thomas Vogl, Carl S. Goodyear, Peter M. Kraan, Peter L. Lent, Martijn H. Bosch. The alarmin S100A9 hampers osteoclast differentiation from human circulating precursors by reducing the expression of RANK. The FASEB Journal 2019; 33(9): 10104 doi: 10.1096/fj.201802691RR
|
| 83 |
Safaa I. Khater, Marwa M. Lotfy, Maher N. Alandiyjany, Leena S. Alqahtani, Asmaa W. Zaglool, Fayez Althobaiti, Tamer Ahmed Ismail, Mohamed Mohamed Soliman, Saydat Saad, Doaa Ibrahim. Therapeutic Potential of Quercetin Loaded Nanoparticles: Novel Insights in Alleviating Colitis in an Experimental DSS Induced Colitis Model. Biomedicines 2022; 10(7): 1654 doi: 10.3390/biomedicines10071654
|
| 84 |
Marie-Alice Meuwis, Marianne Fillet, Pierre Geurts, Dominique de Seny, Laurence Lutteri, Jean-Paul Chapelle, Vincent Bours, Louis Wehenkel, Jacques Belaiche, Michel Malaise, Edouard Louis, Marie-Paule Merville. Biomarker discovery for inflammatory bowel disease, using proteomic serum profiling. Biochemical Pharmacology 2007; 73(9): 1422 doi: 10.1016/j.bcp.2006.12.019
|
| 85 |
Laszlo Lakatos, Gabor Mester, Zsuzsanna Erdelyi, Mihaly Balogh, Istvan Szipocs, Gyorgy Kamaras, Peter Laszlo Lakatos. Striking elevation in incidence and prevalence of inflammatory bowel disease in a province of western Hungary between 1977-2001. World Journal of Gastroenterology 2004; 10(3): 404-409 doi: 10.3748/wjg.v10.i3.404
|
| 86 |
|
| 87 |
Andy Xavier, Annabelle Cesaro. Impact of Exercise Intensity on Calprotectin Levels in Healthy Volunteers and Patients with Inflammatory Rheumatic Diseases. Life 2021; 11(5): 377 doi: 10.3390/life11050377
|
| 88 |
Kayalvily Jesuratnam-Nielsen, Vibeke B. Løgager, Pia Munkholm, Yousef W. Nielsen, Henrik S. Thomsen. Comparison of a New Magnetic Resonance Imaging Protocol and Magnetic Resonance Follow-Through in Patients with Inflammatory Bowel Disease—A Prospective Pilot Study. Open Journal of Radiology 2015; 5(02): 117 doi: 10.4236/ojrad.2015.52018
|
| 89 |
Kurvi Patwala, Peter De Cruz. Biomarkers in Inflammatory Bowel Diseases. 2019; : 89 doi: 10.1007/978-3-030-11446-6_8
|
| 90 |
Jost Langhorst, Sigrid Elsenbruch, Twyla Mueller, Andreas Rueffer, Guenther Spahn, Andreas Michalsen, Gustav J Dobos. Comparison of 4 Neutrophil-Derived Proteins in Feces As Indicators of Disease Activity in Ulcerative Colitis. Inflammatory Bowel Diseases 2005; 11(12): 1085 doi: 10.1097/01.MIB.0000187980.08686.18
|
| 91 |
Marzena Komraus, Halina Wos, Sabina Wiecek, Maciej Kajor, Urszula Grzybowska-Chlebowczyk. Usefulness of Faecal Calprotectin Measurement in Children with Various Types of Inflammatory Bowel Disease. Mediators of Inflammation 2012; 2012: 1 doi: 10.1155/2012/608249
|
| 92 |
Athanasios Kostas, Spyros I Siakavellas, Charalambos Kosmidis, Anna Takou, Joanna Nikou, Georgios Maropoulos, John Vlachogiannakos, George V Papatheodoridis, Ioannis Papaconstantinou, Giorgos Bamias. Fecal calprotectin measurement is a marker of short-term clinical outcome and presence of mucosal healing in patients with inflammatory bowel disease. World Journal of Gastroenterology 2017; 23(41): 7387-7396 doi: 10.3748/wjg.v23.i41.7387
|
| 93 |
Shokoufeh Ahmadipour, Mehri Najafi, Farzaneh Motamed, Parisa Rahmani. Feeding-based treatment of allergic proctocolitis and associated clinical outcomes. Clinical Nutrition ESPEN 2020; 40: 237 doi: 10.1016/j.clnesp.2020.09.013
|
| 94 |
Kohki Okada, Masaki Ikemoto. A New Hybrid Protein Is a Novel Regulator for Experimental Colitis in Rats. Inflammation 2022; 45(1): 180 doi: 10.1007/s10753-021-01537-5
|
| 95 |
J.L. Mendoza, M.T. Abreu. Biological markers in inflammatory bowel disease: Practical consideration for clinicians. Gastroentérologie Clinique et Biologique 2009; 33: S158 doi: 10.1016/S0399-8320(09)73151-3
|
| 96 |
Katarzyna Akutko, Barbara Iwańczak. Evaluation of Fecal Calprotectin, Serum C-Reactive Protein, Erythrocyte Sedimentation Rate, Seromucoid and Procalcitonin in the Diagnostics and Monitoring of Crohn’s Disease in Children. Journal of Clinical Medicine 2022; 11(20): 6086 doi: 10.3390/jcm11206086
|
| 97 |
Maryam Samsami-kor, Naser Ebrahimi Daryani, Parisa Rezanejad Asl, Azita Hekmatdoost. Anti-Inflammatory Effects of Resveratrol in Patients with Ulcerative Colitis: A Randomized, Double-Blind, Placebo-controlled Pilot Study. Archives of Medical Research 2015; 46(4): 280 doi: 10.1016/j.arcmed.2015.05.005
|
| 98 |
Antonella Russo, Hendrik Schürmann, Matthias Brandt, Katja Scholz, Anna Livia L. Matos, David Grill, Julian Revenstorff, Maximilian Rembrink, Meike von Wulffen, Lena Fischer‐Riepe, Peter J. Hanley, Hans Häcker, Monika Prünster, Francisco Sánchez‐Madrid, Sven Hermann, Luisa Klotz, Volker Gerke, Timo Betz, Thomas Vogl, Johannes Roth. Alarming and Calming: Opposing Roles of S100A8/S100A9 Dimers and Tetramers on Monocytes. Advanced Science 2022; 9(36) doi: 10.1002/advs.202201505
|
| 99 |
Peter Townsend, Melissa Fernandes. Pediatric Gastrointestinal and Liver Disease. 2021; : 88 doi: 10.1016/B978-0-323-67293-1.00009-8
|
| 100 |
Marco Scarpa, Renata D'Incà, Daniela Basso, Cesare Ruffolo, Lino Polese, Eugenia Bertin, Alessia Luise, Mauro Frego, Mario Plebani, Giacomo C. Sturniolo, Davide F. D'Amico, Imerio Angriman. Fecal Lactoferrin and Calprotectin After Ileocolonic Resection for Crohn's Disease. Diseases of the Colon & Rectum 2007; 50(6): 861 doi: 10.1007/s10350-007-0225-6
|
| 101 |
Javier P. Gisbert, Yago González-Lama, José Maté. Papel de los marcadores biológicos en la enfermedad inflamatoria intestinal. Gastroenterología y Hepatología 2007; 30(3): 117 doi: 10.1157/13100073
|
| 102 |
George Vaos, Ioannis D. Kostakis, Nick Zavras, Athanasios Chatzemichael. The Role of Calprotectin in Pediatric Disease. BioMed Research International 2013; 2013: 1 doi: 10.1155/2013/542363
|
| 103 |
Javier P. Gisbert, Fernando Bermejo, Jose-Lázaro Pérez-Calle, Carlos Taxonera, Isabel Vera, Adrian G. McNicholl, Alicia Algaba, Pilar López, Natalia López-Palacios, Marta Calvo, Yago González-Lama, Jose-Antonio Carneros, Marta Velasco, José Maté. Fecal calprotectin and lactoferrin for the prediction of inflammatory bowel disease relapse. Inflammatory Bowel Diseases 2009; 15(8): 1190 doi: 10.1002/ibd.20933
|
| 104 |
Claudia I. Reinders, Daisy Jonkers, Emmelie Å. Jansson, Reinhold W. Stockbrügger, Ellen E. Stobberingh, Per M. Hellström, Jon O. Lundberg. Rectal nitric oxide and fecal calprotectin in inflammatory bowel disease. Scandinavian Journal of Gastroenterology 2007; 42(10): 1151 doi: 10.1080/00365520701320505
|
| 105 |
R. González, D. Ceacero-Heras, M. Tena-Garitaonaindia, A. Álvarez-Mercado, R. Gámez-Belmonte, W.J. Chazin, F. Sánchez de Medina, O. Martínez-Augustin. Intestinal inflammation marker calprotectin regulates epithelial intestinal zinc metabolism and proliferation in mouse jejunal organoids. Biomedicine & Pharmacotherapy 2024; 174: 116555 doi: 10.1016/j.biopha.2024.116555
|
| 106 |
A. Damms, S. C. Bischoff. Validation and clinical significance of a new calprotectin rapid test for the diagnosis of gastrointestinal diseases. International Journal of Colorectal Disease 2008; 23(10): 985 doi: 10.1007/s00384-008-0506-0
|
| 107 |
Islaine Martins NOGUEIRA, Sender Jankiel MISZPUTEN, Orlando AMBROGINI Jr., Ricardo ARTIGIANI-NETO, Cláudia Teresa CARVENTE, Maria Ivani ZANON. ASSESSMENT OF THE RESPONSE OF PATIENTS WITH CROHN'S DISEASE TO BIOLOGICAL THERAPY USING NEW NON-INVASIVE MARKERS: lactoferrin and calprotectin. Arquivos de Gastroenterologia 2013; 50(2): 130 doi: 10.1590/S0004-28032013000200022
|
| 108 |
Ying Cao, Yibei Dai, Lingyu Zhang, Danhua Wang, Wen Hu, Qiao Yu, Xuchu Wang, Pan Yu, Weiwei Liu, Ying Ping, Tao Sun, Yiwen Sang, Zhenping Liu, Yan Chen, Zhihua Tao. Combined Use of Fecal Biomarkers in Inflammatory Bowel Diseases: Oncostatin M and Calprotectin. Journal of Inflammation Research 2021; : 6409 doi: 10.2147/JIR.S342846
|
| 109 |
A. Diamanti, F. Panetta, M. S. Basso, A. Forgione, F. Colistro, F. Bracci, B. Papadatou, P. Francalanci, F. Torroni, D. Knafelz, F. Fina, M. Castro. Diagnostic work-up of inflammatory bowel disease in children: The role of calprotectin assay. Inflammatory Bowel Diseases 2010; 16(11): 1926 doi: 10.1002/ibd.21257
|
| 110 |
Carlos J Aranda, Borja Ocón, María Arredondo‐Amador, María Dolores Suárez, Antonio Zarzuelo, Walter J Chazin, Olga Martínez‐Augustin, Fermín Sánchez de Medina. Calprotectin protects against experimental colonic inflammation in mice. British Journal of Pharmacology 2018; 175(19): 3797 doi: 10.1111/bph.14449
|
| 111 |
Kohki Okada, Satoshi Arai, Hiroshi Itoh, Souichi Adachi, Masahiko Hayashida, Hiroshi Nakase, Masaki Ikemoto. CD68 on rat macrophages binds tightly to S100A8 and S100A9 and helps to regulate the cells’ immune functions. Journal of Leukocyte Biology 2016; 100(5): 1093 doi: 10.1189/jlb.2A0415-170RRR
|
| 112 |
Stanisław Pieczarkowski, Kinga Kowalska-Duplaga, Przemko Kwinta, Przemysław Tomasik, Andrzej Wędrychowicz, Krzysztof Fyderek. Diagnostic Value of Fecal Calprotectin (S100 A8/A9) Test in Children with Chronic Abdominal Pain. Gastroenterology Research and Practice 2016; 2016: 1 doi: 10.1155/2016/8089217
|
| 113 |
Jost Langhorst, James Boone, Romy Lauche, Andreas Rueffer, Gustav Dobos. Faecal Lactoferrin, Calprotectin, PMN-elastase, CRP, and White Blood Cell Count as Indicators for Mucosal Healing and Clinical Course of Disease in Patients with Mild to Moderate Ulcerative Colitis: Post Hoc Analysis of a Prospective Clinical Trial. Journal of Crohn's and Colitis 2016; 10(7): 786 doi: 10.1093/ecco-jcc/jjw044
|
| 114 |
Imerio Angriman, Marco Scarpa, Renata D'Incà, Daniela Basso, Cesare Ruffolo, Lino Polese, Giacomo C. Sturniolo, Davide F. D'Amico, Mario Plebani. Enzymes in feces: Useful markers of chronic inflammatory bowel disease. Clinica Chimica Acta 2007; 381(1): 63 doi: 10.1016/j.cca.2007.02.025
|
| 115 |
Jean Guibourdenche, Dominique Berrebi, Edith Vuillard, Pascal de Lagausie, Yves Aigrain, Jean-François Oury, Dominique Luton. Biochemical Investigations of Bowel Inflammation in Gastroschisis. Pediatric Research 2006; 60(5): 565 doi: 10.1203/01.pdr.0000242344.22638.94
|
| 116 |
Xiao-Hua Jiang, Ning Li, Jie-Shou Li. Intestinal permeability in patients after surgical trauma and effect of enteral nutrition versus parenteral nutrition. World Journal of Gastroenterology 2003; 9(8): 1878-1880 doi: 10.3748/wjg.v9.i8.1878
|
| 117 |
Rafail I. Kushak, Timothy M. Buie, Katherine F. Murray, David S. Newburg, Ceng Chen, Eirini Nestoridi, Harland S. Winter. Evaluation of Intestinal Function in Children With Autism and Gastrointestinal Symptoms. Journal of Pediatric Gastroenterology and Nutrition 2016; 62(5): 687 doi: 10.1097/MPG.0000000000001174
|
| 118 |
Levent Filik, Ulku Dagli, Aysel Ulker. C-reactive protein and monitoring the activity of Crohn’s disease. Advances in Therapy 2006; 23(4): 655 doi: 10.1007/BF02850054
|
| 119 |
Linn A. Brunborg, Tor M. Madland, Ragna A. Lind, Gülen Arslan, Arnold Berstad, Livar Frøyland. Effects of short-term oral administration of dietary marine oils in patients with inflammatory bowel disease and joint pain: A pilot study comparing seal oil and cod liver oil. Clinical Nutrition 2008; 27(4): 614 doi: 10.1016/j.clnu.2008.01.017
|